Prokinetic agents and gastric decompression Prokinetic agents such as metoclopramide may be considered in selected clinical contexts, but current evidence is insufficient to rely on them as a predictable solution for GLP-1-associated retained gastric contents
As with previous dual agonists, the main side effects were gastrointestinal and occurred mostly during the initial dose escalation
As Komodos recent published analyses have shown, tools like Marmot can help translate complex real-world treatment patterns into practical, decision-ready evidence, making it easier to understand how patients move through care as therapies, labels, and clinical practice continue to evolve
However, evidence also shows that when GLP-1 medications are stopped, many patients regain much of the weight
he pays $1,300
For patients who have undergone upper gastrointestinal procedures, the oral glucose tolerance test (OGTT) is often poorly tolerated due to the potential for severe dumping syndrome